Aerovate Therapeutics
AVTE
$20.57
Share price
-6.12%
Change (1 day)
7.30%
Change (1 year)
Categories
Aerovate Therapeutics (AVTE) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $17.96 M
According to Aerovate Therapeutics's latest financial reports the company's total liabilities are $17.96 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Aerovate Therapeutics - Total liabilities on balance sheet (from 2020 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $8.55 M | 190.59% |
| 2021-12-31 | $2.94 M | -83.69% |
| 2020-12-31 | $18.05 M | 152.33% |
| 2019-12-31 | $7.15 M |